All stories tagged :

Sample Category Title

Apogee Therapeutics to Host Conference Call to Report Part A 16-Week...

admin
Pr Newswire

Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological...

admin
Pr Newswire

EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or...

admin
Pr Newswire

Dr. Kevin Cross Is Featured as a Top Doc in Philadelphia

admin
Pr Newswire

Press Release: Dupixent positive phase 3 data in children one to...

admin
Pr Newswire

Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11...

admin
People

Athli App Announces Expansion with the Addition of Three New Trainers

admin
People

Home Deals with Damon Unveils the Ultimate Mosquito Repellent Solution for...

admin
Pr Newswire

Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to...

admin
Pr Newswire

Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient

admin
Pr Newswire

DeepL goes global, bringing innovative Language AI solution to 165 new...

admin

Featured

Pr Newswire

iQIYI Partners with Telkomsel to Enhance Indonesian User Experience and Expand...

admin
Pr Newswire

Skywork-Reward-V2: Leading the New Milestone for Open-Source Reward Models

admin
Pr Newswire

13th World Peace Forum held in Beijing, calls for shared responsibility...

admin
People

Kering: Half yearly achievement report on Kering share quotations liquidity mandate...

admin
admin

iQIYI Partners with Telkomsel to Enhance Indonesian User Experience and Expand...

SINGAPORE, July 6, 2025 /PRNewswire/ -- Leading Asian streaming platform iQIYI has announced a significant strategic partnership with Telkomsel, Indonesia's largest telecom provider, recently. Both companies will collaborate extensively on content production, promotional service packages, and joint marketing initiatives, accelerating the delivery of high-quality content in the Indonesian market...